DK131084A - Egolinderivater, fremgangsmaade til fremstilling heraf samt anvendelsen heraf som laegemiddel - Google Patents

Egolinderivater, fremgangsmaade til fremstilling heraf samt anvendelsen heraf som laegemiddel Download PDF

Info

Publication number
DK131084A
DK131084A DK131084A DK131084A DK131084A DK 131084 A DK131084 A DK 131084A DK 131084 A DK131084 A DK 131084A DK 131084 A DK131084 A DK 131084A DK 131084 A DK131084 A DK 131084A
Authority
DK
Denmark
Prior art keywords
hydrogen
alkyl
egolin
medicine
derivatives
Prior art date
Application number
DK131084A
Other languages
Danish (da)
English (en)
Other versions
DK131084D0 (da
Inventor
Gerhard Sauer
Gregor Haffer
Helmut Wachtel
Herbert Hans Schneider
Wolfgang Kehr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK131084D0 publication Critical patent/DK131084D0/da
Publication of DK131084A publication Critical patent/DK131084A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK131084A 1983-03-14 1984-02-29 Egolinderivater, fremgangsmaade til fremstilling heraf samt anvendelsen heraf som laegemiddel DK131084A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3309493A DE3309493A1 (de) 1983-03-14 1983-03-14 Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
DK131084D0 DK131084D0 (da) 1984-02-29
DK131084A true DK131084A (da) 1984-09-15

Family

ID=6193690

Family Applications (1)

Application Number Title Priority Date Filing Date
DK131084A DK131084A (da) 1983-03-14 1984-02-29 Egolinderivater, fremgangsmaade til fremstilling heraf samt anvendelsen heraf som laegemiddel

Country Status (11)

Country Link
US (1) US4766128A (cs)
EP (1) EP0118848B1 (cs)
JP (1) JPS59176285A (cs)
AT (1) ATE72667T1 (cs)
AU (1) AU567333B2 (cs)
CA (1) CA1253488A (cs)
CS (1) CS241071B2 (cs)
DE (2) DE3309493A1 (cs)
DK (1) DK131084A (cs)
GR (1) GR81772B (cs)
HU (1) HU191396B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3445784A1 (de) * 1984-12-13 1986-06-26 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von ergolin-derivaten
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
DE3522894A1 (de) * 1985-06-24 1987-01-02 Schering Ag Verwendung von tergurid als geriatrikum
DE3528584A1 (de) * 1985-08-06 1987-02-19 Schering Ag Neue 1-alkyl-ergolin-thioharnstoffderivate
DE3533672A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-substituierte ergolinderivate
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3535929A1 (de) * 1985-10-04 1987-04-09 Schering Ag 1,2-disubstituierte ergolinderivate
DE3535930A1 (de) * 1985-10-04 1987-04-09 Schering Ag Neue 2-substituierte ergolinderivate
DE3623503A1 (de) * 1986-07-09 1988-01-21 Schering Ag 1-aryl-ergolinyl-harnstoffderivate, verfahren zu deren herstellung sowie die verwendung dieser verbindungen als arzneimittel
DE3806374A1 (de) * 1988-02-25 1989-09-07 Schering Ag Neue ergolin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
DE69330601T2 (de) * 1992-12-24 2002-07-04 Pharmacia & Upjohn Spa Serotoninergische ergolin derivate

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278401A (cs) * 1961-05-29
GB1191099A (en) * 1968-03-07 1970-05-06 Farmaceutici Italia Ergoline Derivatives
JPS4524785Y1 (cs) * 1968-04-20 1970-09-29
SE393615B (sv) * 1971-05-19 1977-05-16 Sandoz Ag Forfarande for framstellning av 6-metyl-8 beta-ureidometyl-ergolener
CH573936A5 (cs) * 1971-08-05 1976-03-31 Spofa Vereinigte Pharma Werke
US3992385A (en) * 1975-01-20 1976-11-16 Eli Lilly And Company 2,3-Dihydroergolines
DE2924102A1 (de) * 1979-06-13 1980-12-18 Schering Ag Neue (ergolin-yl)-n'.n'-diaethylharnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
EP0021206B1 (de) * 1979-06-13 1983-06-22 Schering Aktiengesellschaft Neue (Ergolin-yl)-N', N'-diäthylharnstoff-Derivate, ihre Herstellung und sie enthaltende Arzneimittel
CH644606A5 (de) * 1980-09-23 1984-08-15 Sandoz Ag Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3205169A1 (de) * 1981-02-24 1982-10-14 Sandoz-Patent-GmbH, 7850 Lörrach Neue ergolinderivate, deren herstellung und deren pharmazeutische zusammensetzungen
DE3135305C2 (de) * 1981-09-03 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen
CS231214B1 (en) * 1982-03-12 1984-10-15 Antonin Cerny Processing method of 1-substituted n+l8alpha-ergoline+p-n,diethyl urea

Also Published As

Publication number Publication date
HU191396B (en) 1987-02-27
DE3309493A1 (de) 1984-09-20
JPS59176285A (ja) 1984-10-05
CS170784A2 (en) 1985-06-13
EP0118848A2 (de) 1984-09-19
US4766128A (en) 1988-08-23
AU567333B2 (en) 1987-11-19
AU2560684A (en) 1984-09-20
EP0118848B1 (de) 1992-02-19
CA1253488A (en) 1989-05-02
DE3485512D1 (de) 1992-03-26
CS241071B2 (en) 1986-03-13
GR81772B (cs) 1984-12-12
EP0118848A3 (en) 1985-12-04
DK131084D0 (da) 1984-02-29
ATE72667T1 (de) 1992-03-15

Similar Documents

Publication Publication Date Title
DK131084D0 (da) Egolinderivater,fremgangsmaade til fremstilling heraf samt anvendelsen heraf som laegemiddel
DE3650184D1 (de) Zellenfreier t-zellenantigenrezeptor und klinische verwendung.
ATE76069T1 (de) 5-nitrobenzo(de>isochinolin-1,3-dione, ihre herstellung und verwendung.
EP0261539A3 (en) Substituted phenyl-sulphon amides
ZA845160B (en) Derivatives of 2.azabicyclo(3.1.0)hexane-3-carboxylic acid,a process for their preparation,agents containing them and their use,and 2-azabicyclo(3.1.0)hexane derivatives as intermediates,and a process for their preparation
BG51918A1 (en) Composition to prevent seasickness (nausea)
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
SE8703854D0 (sv) Prostaglandinderivat for behandling av glaukom eller okuler hypertension
IL83804A (en) Imidazolylguanidine derivatives, processes for preparing them and pharmaceutical compositions containing them
DE3688397D1 (de) 3-(2-aminoethyl)indol und -indolinderivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
ZA879186B (en) 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8-inter-m-phenylene pgi2 derivatives
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
EP0313945A3 (de) Mittel zur Behandlung des Bluthochdrucks und der Herzinsuffizienz
DE3780542D1 (en) Substituierte hexahydroarylchinolizine.
NO880325D0 (no) Fremgangsmaate for fremstilling av n,n-(dibenzoheksatrienylen)ureaer.
ATE78039T1 (de) Jomol, seine derivate, verfahren zur herstellung dieser verbindungen, ihre verwendung und erzeugnis.
ATE21483T1 (de) Glycerinmononitrate zur behandlung der angina pectoris.
CS548987A2 (en) Process for preparing new tetracycline derivatives of indole
DE3788888D1 (de) Perhydrothiazepin- und Perhydroazepinderivate, ihre Herstellung und ihre therapeutische Verwendung.
IT8619931A0 (it) Procedimento per la preparazione della 1-(n-metilamidino)-3-(2,6-dimetilfe nil) urea e dei suoi sali farmaceuticamente accettabili.
NO883223L (no) Middel og fremgangsmaate for oxyderende farving av haar med3-(2',2', 2'-trifluorethyl)aminofenolderivater.
DE3767504D1 (de) Tetrahydrobenz(c,d)indol-derivate, ihre salze, verfahren zur herstellung, verwendung als arzneimittel, ihre zusammensetzungen und zwischenprodukte.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment